APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Short-Acting Anesthetic

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Short-Acting Anesthetic Market Analysis and Forecast 2026-2032

Report ID 174035220230 December 2025207 pages

Choose your research edition.

Industry ResearchShort-Acting Anesthetic Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Short-Acting Anesthetic Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Short-Acting Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short-Acting Anesthetic Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Short-Acting Anesthetic Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Short-Acting Anesthetic market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Short-Acting Anesthetic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Short-Acting Anesthetic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Short-Acting Anesthetic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Short-Acting Anesthetic is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Short-Acting Anesthetic include Aspen Pharmacare, Baxter Healthcare, Dr. Reddy's Laboratories, Fresenius-Kabi, Hikma Pharmaceuticals, Hospira, Paion, Piramal Critical Care and Septodont, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Short-Acting Anesthetic, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Short-Acting Anesthetic, also provides the sales of main regions and countries. Of the upcoming market potential for Short-Acting Anesthetic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Short-Acting Anesthetic sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Short-Acting Anesthetic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Short-Acting Anesthetic sales, projected growth trends, production technology, application and end-user industry.

Short-Acting Anesthetic Segment by Company

Aspen Pharmacare

Baxter Healthcare

Dr. Reddy's Laboratories

Fresenius-Kabi

Hikma Pharmaceuticals

Hospira

Paion

Piramal Critical Care

Septodont

AstraZeneca

AbbVie

B. Braun

Cisen Pharmaceutical

Pfizer

Yingke Biopharmaceutical

SSY Group

Baili-Pharm

Eisai

Short-Acting Anesthetic Segment by Type

Local

General

Short-Acting Anesthetic Segment by Application

Hospital

Clinic

Short-Acting Anesthetic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-Acting Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short-Acting Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-Acting Anesthetic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Short-Acting Anesthetic in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Short-Acting Anesthetic manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Short-Acting Anesthetic sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Short-Acting Anesthetic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Local Major Manufacturers Table 3. General Major Manufacturers Table 4. Global Short-Acting Anesthetic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Short-Acting Anesthetic Industry Trends Table 8. Short-Acting Anesthetic Industry Drivers Table 9. Short-Acting Anesthetic Industry Opportunities and Challenges Table 10. Short-Acting Anesthetic Industry Restraints Table 11. Global Short-Acting Anesthetic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Short-Acting Anesthetic Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Short-Acting Anesthetic Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Short-Acting Anesthetic Revenue Market Share by Region (2021-2026) Table 15. Global Short-Acting Anesthetic Revenue Market Share by Region (2027-2032) Table 16. Global Short-Acting Anesthetic Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Short-Acting Anesthetic Sales by Region (2021-2026) & (K Units) Table 18. Global Short-Acting Anesthetic Sales by Region (2027-2032) & (K Units) Table 19. Global Short-Acting Anesthetic Sales Market Share by Region (2021-2026) Table 20. Global Short-Acting Anesthetic Sales Market Share by Region (2027-2032) Table 21. Global Short-Acting Anesthetic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Short-Acting Anesthetic Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Short-Acting Anesthetic Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Short-Acting Anesthetic Sales Market Share by Manufacturers (2021-2026) Table 25. Global Short-Acting Anesthetic Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Short-Acting Anesthetic Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Short-Acting Anesthetic Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Short-Acting Anesthetic Manufacturers, Product Type & Application Table 29. Global Short-Acting Anesthetic Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Short-Acting Anesthetic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Short-Acting Anesthetic Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Short-Acting Anesthetic Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Short-Acting Anesthetic Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2026) Table 36. Global Short-Acting Anesthetic Revenue Market Share by Type (2027-2032) Table 37. Global Short-Acting Anesthetic Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 39. Global Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 40. Global Short-Acting Anesthetic Sales Market Share by Type (2021-2026) Table 41. Global Short-Acting Anesthetic Sales Market Share by Type (2027-2032) Table 42. Global Short-Acting Anesthetic Price by Type (2021-2026) & (US$/Unit) Table 43. Global Short-Acting Anesthetic Price by Type (2027-2032) & (US$/Unit) Table 44. Global Short-Acting Anesthetic Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Short-Acting Anesthetic Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Short-Acting Anesthetic Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2026) Table 48. Global Short-Acting Anesthetic Revenue Market Share by Application (2027-2032) Table 49. Global Short-Acting Anesthetic Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 51. Global Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 52. Global Short-Acting Anesthetic Sales Market Share by Application (2021-2026) Table 53. Global Short-Acting Anesthetic Sales Market Share by Application (2027-2032) Table 54. Global Short-Acting Anesthetic Price by Application (2021-2026) & (US$/Unit) Table 55. Global Short-Acting Anesthetic Price by Application (2027-2032) & (US$/Unit) Table 56. Aspen Pharmacare Company Information Table 57. Aspen Pharmacare Business Overview Table 58. Aspen Pharmacare Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Aspen Pharmacare Short-Acting Anesthetic Product Portfolio Table 60. Aspen Pharmacare Recent Development Table 61. Baxter Healthcare Company Information Table 62. Baxter Healthcare Business Overview Table 63. Baxter Healthcare Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Baxter Healthcare Short-Acting Anesthetic Product Portfolio Table 65. Baxter Healthcare Recent Development Table 66. Dr. Reddy's Laboratories Company Information Table 67. Dr. Reddy's Laboratories Business Overview Table 68. Dr. Reddy's Laboratories Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio Table 70. Dr. Reddy's Laboratories Recent Development Table 71. Fresenius-Kabi Company Information Table 72. Fresenius-Kabi Business Overview Table 73. Fresenius-Kabi Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Fresenius-Kabi Short-Acting Anesthetic Product Portfolio Table 75. Fresenius-Kabi Recent Development Table 76. Hikma Pharmaceuticals Company Information Table 77. Hikma Pharmaceuticals Business Overview Table 78. Hikma Pharmaceuticals Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio Table 80. Hikma Pharmaceuticals Recent Development Table 81. Hospira Company Information Table 82. Hospira Business Overview Table 83. Hospira Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hospira Short-Acting Anesthetic Product Portfolio Table 85. Hospira Recent Development Table 86. Paion Company Information Table 87. Paion Business Overview Table 88. Paion Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Paion Short-Acting Anesthetic Product Portfolio Table 90. Paion Recent Development Table 91. Piramal Critical Care Company Information Table 92. Piramal Critical Care Business Overview Table 93. Piramal Critical Care Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Piramal Critical Care Short-Acting Anesthetic Product Portfolio Table 95. Piramal Critical Care Recent Development Table 96. Septodont Company Information Table 97. Septodont Business Overview Table 98. Septodont Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Septodont Short-Acting Anesthetic Product Portfolio Table 100. Septodont Recent Development Table 101. AstraZeneca Company Information Table 102. AstraZeneca Business Overview Table 103. AstraZeneca Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. AstraZeneca Short-Acting Anesthetic Product Portfolio Table 105. AstraZeneca Recent Development Table 106. AbbVie Company Information Table 107. AbbVie Business Overview Table 108. AbbVie Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. AbbVie Short-Acting Anesthetic Product Portfolio Table 110. AbbVie Recent Development Table 111. B. Braun Company Information Table 112. B. Braun Business Overview Table 113. B. Braun Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. B. Braun Short-Acting Anesthetic Product Portfolio Table 115. B. Braun Recent Development Table 116. Cisen Pharmaceutical Company Information Table 117. Cisen Pharmaceutical Business Overview Table 118. Cisen Pharmaceutical Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio Table 120. Cisen Pharmaceutical Recent Development Table 121. Pfizer Company Information Table 122. Pfizer Business Overview Table 123. Pfizer Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Pfizer Short-Acting Anesthetic Product Portfolio Table 125. Pfizer Recent Development Table 126. Yingke Biopharmaceutical Company Information Table 127. Yingke Biopharmaceutical Business Overview Table 128. Yingke Biopharmaceutical Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio Table 130. Yingke Biopharmaceutical Recent Development Table 131. SSY Group Company Information Table 132. SSY Group Business Overview Table 133. SSY Group Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. SSY Group Short-Acting Anesthetic Product Portfolio Table 135. SSY Group Recent Development Table 136. Baili-Pharm Company Information Table 137. Baili-Pharm Business Overview Table 138. Baili-Pharm Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Baili-Pharm Short-Acting Anesthetic Product Portfolio Table 140. Baili-Pharm Recent Development Table 141. Eisai Company Information Table 142. Eisai Business Overview Table 143. Eisai Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Eisai Short-Acting Anesthetic Product Portfolio Table 145. Eisai Recent Development Table 146. North America Short-Acting Anesthetic Revenue by Type (2021-2026) & (US$ Million) Table 147. North America Short-Acting Anesthetic Revenue by Type (2027-2032) & (US$ Million) Table 148. North America Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 149. North America Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 150. North America Short-Acting Anesthetic Sales Price by Type (2021-2026) & (US$/Unit) Table 151. North America Short-Acting Anesthetic Sales Price by Type (2027-2032) & (US$/Unit) Table 152. North America Short-Acting Anesthetic Revenue by Application (2021-2026) & (US$ Million) Table 153. North America Short-Acting Anesthetic Revenue by Application (2027-2032) & (US$ Million) Table 154. North America Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 155. North America Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 156. North America Short-Acting Anesthetic Sales Price by Application (2021-2026) & (US$/Unit) Table 157. North America Short-Acting Anesthetic Sales Price by Application (2027-2032) & (US$/Unit) Table 158. North America Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. North America Short-Acting Anesthetic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. North America Short-Acting Anesthetic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. North America Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. North America Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 163. North America Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 164. North America Short-Acting Anesthetic Sales Price by Country (2021-2026) & (US$/Unit) Table 165. North America Short-Acting Anesthetic Sales Price by Country (2027-2032) & (US$/Unit) Table 166. United States Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 167. Canada Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 168. Europe Short-Acting Anesthetic Revenue by Type (2021-2026) & (US$ Million) Table 169. Europe Short-Acting Anesthetic Revenue by Type (2027-2032) & (US$ Million) Table 170. Europe Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 171. Europe Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 172. Europe Short-Acting Anesthetic Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Europe Short-Acting Anesthetic Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Europe Short-Acting Anesthetic Revenue by Application (2021-2026) & (US$ Million) Table 175. Europe Short-Acting Anesthetic Revenue by Application (2027-2032) & (US$ Million) Table 176. Europe Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 177. Europe Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 178. Europe Short-Acting Anesthetic Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Europe Short-Acting Anesthetic Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Europe Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Europe Short-Acting Anesthetic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Europe Short-Acting Anesthetic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Europe Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. Europe Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 185. Europe Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 186. Europe Short-Acting Anesthetic Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Europe Short-Acting Anesthetic Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Germany Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 189. France Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 190. U.K. Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 191. Italy Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 192. Netherlands Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 193. China Short-Acting Anesthetic Revenue by Type (2021-2026) & (US$ Million) Table 194. China Short-Acting Anesthetic Revenue by Type (2027-2032) & (US$ Million) Table 195. China Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 196. China Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 197. China Short-Acting Anesthetic Sales Price by Type (2021-2026) & (US$/Unit) Table 198. China Short-Acting Anesthetic Sales Price by Type (2027-2032) & (US$/Unit) Table 199. China Short-Acting Anesthetic Revenue by Application (2021-2026) & (US$ Million) Table 200. China Short-Acting Anesthetic Revenue by Application (2027-2032) & (US$ Million) Table 201. China Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 202. China Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 203. China Short-Acting Anesthetic Sales Price by Application (2021-2026) & (US$/Unit) Table 204. China Short-Acting Anesthetic Sales Price by Application (2027-2032) & (US$/Unit) Table 205. Asia Short-Acting Anesthetic Revenue by Type (2021-2026) & (US$ Million) Table 206. Asia Short-Acting Anesthetic Revenue by Type (2027-2032) & (US$ Million) Table 207. Asia Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 208. Asia Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 209. Asia Short-Acting Anesthetic Sales Price by Type (2021-2026) & (US$/Unit) Table 210. Asia Short-Acting Anesthetic Sales Price by Type (2027-2032) & (US$/Unit) Table 211. Asia Short-Acting Anesthetic Revenue by Application (2021-2026) & (US$ Million) Table 212. Asia Short-Acting Anesthetic Revenue by Application (2027-2032) & (US$ Million) Table 213. Asia Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 214. Asia Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 215. Asia Short-Acting Anesthetic Sales Price by Application (2021-2026) & (US$/Unit) Table 216. Asia Short-Acting Anesthetic Sales Price by Application (2027-2032) & (US$/Unit) Table 217. Asia Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. Asia Short-Acting Anesthetic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. Asia Short-Acting Anesthetic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. Asia Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 221. Asia Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 222. Asia Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 223. Asia Short-Acting Anesthetic Sales Price by Country (2021-2026) & (US$/Unit) Table 224. Asia Short-Acting Anesthetic Sales Price by Country (2027-2032) & (US$/Unit) Table 225. Japan Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 226. South Korea Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 227. India Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 228. Australia Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 229. China Taiwan Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 230. Southeast Asia Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 231. SAMEA Short-Acting Anesthetic Revenue by Type (2021-2026) & (US$ Million) Table 232. SAMEA Short-Acting Anesthetic Revenue by Type (2027-2032) & (US$ Million) Table 233. SAMEA Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 234. SAMEA Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 235. SAMEA Short-Acting Anesthetic Sales Price by Type (2021-2026) & (US$/Unit) Table 236. SAMEA Short-Acting Anesthetic Sales Price by Type (2027-2032) & (US$/Unit) Table 237. SAMEA Short-Acting Anesthetic Revenue by Application (2021-2026) & (US$ Million) Table 238. SAMEA Short-Acting Anesthetic Revenue by Application (2027-2032) & (US$ Million) Table 239. SAMEA Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 240. SAMEA Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 241. SAMEA Short-Acting Anesthetic Sales Price by Application (2021-2026) & (US$/Unit) Table 242. SAMEA Short-Acting Anesthetic Sales Price by Application (2027-2032) & (US$/Unit) Table 243. SAMEA Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. SAMEA Short-Acting Anesthetic Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. SAMEA Short-Acting Anesthetic Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. SAMEA Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 247. SAMEA Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 248. SAMEA Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 249. SAMEA Short-Acting Anesthetic Sales Price by Country (2021-2026) & (US$/Unit) Table 250. SAMEA Short-Acting Anesthetic Sales Price by Country (2027-2032) & (US$/Unit) Table 251. Brazil Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 252. Argentina Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 253. Chile Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 254. Colombia Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 255. Peru Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 256. Saudi Arabia Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 257. Israel Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 258. UAE Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 259. Turkey Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 260. Iran Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 261. Egypt Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Table 262. Key Raw Materials Table 263. Raw Materials Key Suppliers Table 264. Short-Acting Anesthetic Distributors List Table 265. Short-Acting Anesthetic Customers List Table 266. Research Programs/Design for This Report Table 267. Authors List of This Report Table 268. Secondary Sources Table 269. Primary Sources List of Figures Figure 1. Short-Acting Anesthetic Image Figure 2. Global Short-Acting Anesthetic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short-Acting Anesthetic Market Size Share 2021 VS 2025 VS 2032 Figure 4. Local Image Figure 5. General Image Figure 6. Global Short-Acting Anesthetic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Short-Acting Anesthetic Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Short-Acting Anesthetic Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Figure 12. Global Short-Acting Anesthetic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Short-Acting Anesthetic Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Short-Acting Anesthetic Revenue Market Share by Region (2021-2032) Figure 15. Global Short-Acting Anesthetic Sales (2021-2032) & (K Units) Figure 16. Global Short-Acting Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Short-Acting Anesthetic Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Short-Acting Anesthetic Sales YoY (2021-2032) & (K Units) Figure 19. Europe Short-Acting Anesthetic Sales YoY (2021-2032) & (K Units) Figure 20. China Short-Acting Anesthetic Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Short-Acting Anesthetic Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Short-Acting Anesthetic Sales YoY (2021-2032) & (K Units) Figure 23. Global Short-Acting Anesthetic Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Short-Acting Anesthetic Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Short-Acting Anesthetic Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Short-Acting Anesthetic Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2032) Figure 29. Global Short-Acting Anesthetic Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Short-Acting Anesthetic Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Short-Acting Anesthetic Sales Market Share by Type (2021-2032) Figure 32. Global Short-Acting Anesthetic Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Short-Acting Anesthetic Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2032) Figure 35. Global Short-Acting Anesthetic Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Short-Acting Anesthetic Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Short-Acting Anesthetic Sales Market Share by Application (2021-2032) Figure 38. North America Short-Acting Anesthetic Revenue Share by Type (2021-2032) Figure 39. North America Short-Acting Anesthetic Sales Share by Type (2021-2032) Figure 40. North America Short-Acting Anesthetic Revenue Share by Application (2021-2032) Figure 41. North America Short-Acting Anesthetic Sales Share by Application (2021-2032) Figure 42. North America Short-Acting Anesthetic Revenue Share by Country (2021-2032) Figure 43. North America Short-Acting Anesthetic Sales Share by Country (2021-2032) Figure 44. Europe Short-Acting Anesthetic Revenue Share by Type (2021-2032) Figure 45. Europe Short-Acting Anesthetic Sales Share by Type (2021-2032) Figure 46. Europe Short-Acting Anesthetic Revenue Share by Application (2021-2032) Figure 47. Europe Short-Acting Anesthetic Sales Share by Application (2021-2032) Figure 48. Europe Short-Acting Anesthetic Revenue Share by Country (2021-2032) Figure 49. Europe Short-Acting Anesthetic Sales Share by Country (2021-2032) Figure 50. China Short-Acting Anesthetic Revenue Share by Type (2021-2032) Figure 51. China Short-Acting Anesthetic Sales Share by Type (2021-2032) Figure 52. China Short-Acting Anesthetic Revenue Share by Application (2021-2032) Figure 53. China Short-Acting Anesthetic Sales Share by Application (2021-2032) Figure 54. Asia Short-Acting Anesthetic Revenue Share by Type (2021-2032) Figure 55. Asia Short-Acting Anesthetic Sales Share by Type (2021-2032) Figure 56. Asia Short-Acting Anesthetic Revenue Share by Application (2021-2032) Figure 57. Asia Short-Acting Anesthetic Sales Share by Application (2021-2032) Figure 58. Asia Short-Acting Anesthetic Revenue Share by Country (2021-2032) Figure 59. Asia Short-Acting Anesthetic Sales Share by Country (2021-2032) Figure 60. SAMEA Short-Acting Anesthetic Revenue Share by Type (2021-2032) Figure 61. SAMEA Short-Acting Anesthetic Sales Share by Type (2021-2032) Figure 62. SAMEA Short-Acting Anesthetic Revenue Share by Application (2021-2032) Figure 63. SAMEA Short-Acting Anesthetic Sales Share by Application (2021-2032) Figure 64. SAMEA Short-Acting Anesthetic Revenue Share by Country (2021-2032) Figure 65. SAMEA Short-Acting Anesthetic Sales Share by Country (2021-2032) Figure 66. Short-Acting Anesthetic Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Short-Acting Anesthetic Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Local
  • General
Applications
  • Hospital
  • Clinic
Companies covered
  • Aspen Pharmacare
  • Baxter Healthcare
  • Dr. Reddy's Laboratories
  • Fresenius-Kabi
  • Hikma Pharmaceuticals
  • Hospira
  • Paion
  • Piramal Critical Care
  • Septodont
  • AstraZeneca
  • AbbVie
  • B. Braun
  • Cisen Pharmaceutical
  • Pfizer
  • Yingke Biopharmaceutical
  • SSY Group
  • Baili-Pharm
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Short-Acting Anesthetic Market by Type
  3. 1.2.1 Global Short-Acting Anesthetic Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Local
  5. 1.2.3 General
  6. 1.3 Short-Acting Anesthetic Market by Application
  7. 1.3.1 Global Short-Acting Anesthetic Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Short-Acting Anesthetic Market Dynamics
  1. 2.1 Short-Acting Anesthetic Industry Trends
  2. 2.2 Short-Acting Anesthetic Industry Drivers
  3. 2.3 Short-Acting Anesthetic Industry Opportunities and Challenges
  4. 2.4 Short-Acting Anesthetic Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Short-Acting Anesthetic Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Short-Acting Anesthetic Revenue by Region
  3. 3.2.1 Global Short-Acting Anesthetic Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Short-Acting Anesthetic Revenue by Region (2021-2026)
  5. 3.2.3 Global Short-Acting Anesthetic Revenue by Region (2027-2032)
  6. 3.2.4 Global Short-Acting Anesthetic Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Short-Acting Anesthetic Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Short-Acting Anesthetic Sales by Region
  9. 3.4.1 Global Short-Acting Anesthetic Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Short-Acting Anesthetic Sales by Region (2021-2026)
  11. 3.4.3 Global Short-Acting Anesthetic Sales by Region (2027-2032)
  12. 3.4.4 Global Short-Acting Anesthetic Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Short-Acting Anesthetic Revenue by Manufacturers
  2. 4.1.1 Global Short-Acting Anesthetic Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Short-Acting Anesthetic Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Short-Acting Anesthetic Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Short-Acting Anesthetic Sales by Manufacturers
  6. 4.2.1 Global Short-Acting Anesthetic Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Short-Acting Anesthetic Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Short-Acting Anesthetic Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Short-Acting Anesthetic Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Short-Acting Anesthetic Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Short-Acting Anesthetic Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Short-Acting Anesthetic Manufacturers, Product Type & Application
  13. 4.7 Global Short-Acting Anesthetic Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Short-Acting Anesthetic Market CR5 and HHI
  16. 4.8.2 2025 Short-Acting Anesthetic Tier 1, Tier 2, and Tier 3
5 Short-Acting Anesthetic Market by Type
  1. 5.1 Global Short-Acting Anesthetic Revenue by Type
  2. 5.1.1 Global Short-Acting Anesthetic Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Short-Acting Anesthetic Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Short-Acting Anesthetic Sales by Type
  6. 5.2.1 Global Short-Acting Anesthetic Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Short-Acting Anesthetic Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Short-Acting Anesthetic Sales Market Share by Type (2021-2032)
  9. 5.3 Global Short-Acting Anesthetic Price by Type
6 Short-Acting Anesthetic Market by Application
  1. 6.1 Global Short-Acting Anesthetic Revenue by Application
  2. 6.1.1 Global Short-Acting Anesthetic Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Short-Acting Anesthetic Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Short-Acting Anesthetic Sales by Application
  6. 6.2.1 Global Short-Acting Anesthetic Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Short-Acting Anesthetic Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Short-Acting Anesthetic Sales Market Share by Application (2021-2032)
  9. 6.3 Global Short-Acting Anesthetic Price by Application
7 Company Profiles
  1. 7.1 Aspen Pharmacare
  2. 7.1.1 Aspen Pharmacare Company Information
  3. 7.1.2 Aspen Pharmacare Business Overview
  4. 7.1.3 Aspen Pharmacare Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aspen Pharmacare Short-Acting Anesthetic Product Portfolio
  6. 7.1.5 Aspen Pharmacare Recent Developments
  7. 7.2 Baxter Healthcare
  8. 7.2.1 Baxter Healthcare Company Information
  9. 7.2.2 Baxter Healthcare Business Overview
  10. 7.2.3 Baxter Healthcare Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Baxter Healthcare Short-Acting Anesthetic Product Portfolio
  12. 7.2.5 Baxter Healthcare Recent Developments
  13. 7.3 Dr. Reddy's Laboratories
  14. 7.3.1 Dr. Reddy's Laboratories Company Information
  15. 7.3.2 Dr. Reddy's Laboratories Business Overview
  16. 7.3.3 Dr. Reddy's Laboratories Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio
  18. 7.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 7.4 Fresenius-Kabi
  20. 7.4.1 Fresenius-Kabi Company Information
  21. 7.4.2 Fresenius-Kabi Business Overview
  22. 7.4.3 Fresenius-Kabi Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fresenius-Kabi Short-Acting Anesthetic Product Portfolio
  24. 7.4.5 Fresenius-Kabi Recent Developments
  25. 7.5 Hikma Pharmaceuticals
  26. 7.5.1 Hikma Pharmaceuticals Company Information
  27. 7.5.2 Hikma Pharmaceuticals Business Overview
  28. 7.5.3 Hikma Pharmaceuticals Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio
  30. 7.5.5 Hikma Pharmaceuticals Recent Developments
  31. 7.6 Hospira
  32. 7.6.1 Hospira Company Information
  33. 7.6.2 Hospira Business Overview
  34. 7.6.3 Hospira Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hospira Short-Acting Anesthetic Product Portfolio
  36. 7.6.5 Hospira Recent Developments
  37. 7.7 Paion
  38. 7.7.1 Paion Company Information
  39. 7.7.2 Paion Business Overview
  40. 7.7.3 Paion Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Paion Short-Acting Anesthetic Product Portfolio
  42. 7.7.5 Paion Recent Developments
  43. 7.8 Piramal Critical Care
  44. 7.8.1 Piramal Critical Care Company Information
  45. 7.8.2 Piramal Critical Care Business Overview
  46. 7.8.3 Piramal Critical Care Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Piramal Critical Care Short-Acting Anesthetic Product Portfolio
  48. 7.8.5 Piramal Critical Care Recent Developments
  49. 7.9 Septodont
  50. 7.9.1 Septodont Company Information
  51. 7.9.2 Septodont Business Overview
  52. 7.9.3 Septodont Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Septodont Short-Acting Anesthetic Product Portfolio
  54. 7.9.5 Septodont Recent Developments
  55. 7.10 AstraZeneca
  56. 7.10.1 AstraZeneca Company Information
  57. 7.10.2 AstraZeneca Business Overview
  58. 7.10.3 AstraZeneca Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 AstraZeneca Short-Acting Anesthetic Product Portfolio
  60. 7.10.5 AstraZeneca Recent Developments
  61. 7.11 AbbVie
  62. 7.11.1 AbbVie Company Information
  63. 7.11.2 AbbVie Business Overview
  64. 7.11.3 AbbVie Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 AbbVie Short-Acting Anesthetic Product Portfolio
  66. 7.11.5 AbbVie Recent Developments
  67. 7.12 B. Braun
  68. 7.12.1 B. Braun Company Information
  69. 7.12.2 B. Braun Business Overview
  70. 7.12.3 B. Braun Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 B. Braun Short-Acting Anesthetic Product Portfolio
  72. 7.12.5 B. Braun Recent Developments
  73. 7.13 Cisen Pharmaceutical
  74. 7.13.1 Cisen Pharmaceutical Company Information
  75. 7.13.2 Cisen Pharmaceutical Business Overview
  76. 7.13.3 Cisen Pharmaceutical Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio
  78. 7.13.5 Cisen Pharmaceutical Recent Developments
  79. 7.14 Pfizer
  80. 7.14.1 Pfizer Company Information
  81. 7.14.2 Pfizer Business Overview
  82. 7.14.3 Pfizer Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Pfizer Short-Acting Anesthetic Product Portfolio
  84. 7.14.5 Pfizer Recent Developments
  85. 7.15 Yingke Biopharmaceutical
  86. 7.15.1 Yingke Biopharmaceutical Company Information
  87. 7.15.2 Yingke Biopharmaceutical Business Overview
  88. 7.15.3 Yingke Biopharmaceutical Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio
  90. 7.15.5 Yingke Biopharmaceutical Recent Developments
  91. 7.16 SSY Group
  92. 7.16.1 SSY Group Company Information
  93. 7.16.2 SSY Group Business Overview
  94. 7.16.3 SSY Group Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 SSY Group Short-Acting Anesthetic Product Portfolio
  96. 7.16.5 SSY Group Recent Developments
  97. 7.17 Baili-Pharm
  98. 7.17.1 Baili-Pharm Company Information
  99. 7.17.2 Baili-Pharm Business Overview
  100. 7.17.3 Baili-Pharm Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Baili-Pharm Short-Acting Anesthetic Product Portfolio
  102. 7.17.5 Baili-Pharm Recent Developments
  103. 7.18 Eisai
  104. 7.18.1 Eisai Company Information
  105. 7.18.2 Eisai Business Overview
  106. 7.18.3 Eisai Short-Acting Anesthetic Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Eisai Short-Acting Anesthetic Product Portfolio
  108. 7.18.5 Eisai Recent Developments
8 North America
  1. 8.1 North America Short-Acting Anesthetic Market Size by Type
  2. 8.1.1 North America Short-Acting Anesthetic Revenue by Type (2021-2032)
  3. 8.1.2 North America Short-Acting Anesthetic Sales by Type (2021-2032)
  4. 8.1.3 North America Short-Acting Anesthetic Price by Type (2021-2032)
  5. 8.2 North America Short-Acting Anesthetic Market Size by Application
  6. 8.2.1 North America Short-Acting Anesthetic Revenue by Application (2021-2032)
  7. 8.2.2 North America Short-Acting Anesthetic Sales by Application (2021-2032)
  8. 8.2.3 North America Short-Acting Anesthetic Price by Application (2021-2032)
  9. 8.3 North America Short-Acting Anesthetic Market Size by Country
  10. 8.3.1 North America Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Short-Acting Anesthetic Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Short-Acting Anesthetic Market Size by Type
  2. 9.1.1 Europe Short-Acting Anesthetic Revenue by Type (2021-2032)
  3. 9.1.2 Europe Short-Acting Anesthetic Sales by Type (2021-2032)
  4. 9.1.3 Europe Short-Acting Anesthetic Price by Type (2021-2032)
  5. 9.2 Europe Short-Acting Anesthetic Market Size by Application
  6. 9.2.1 Europe Short-Acting Anesthetic Revenue by Application (2021-2032)
  7. 9.2.2 Europe Short-Acting Anesthetic Sales by Application (2021-2032)
  8. 9.2.3 Europe Short-Acting Anesthetic Price by Application (2021-2032)
  9. 9.3 Europe Short-Acting Anesthetic Market Size by Country
  10. 9.3.1 Europe Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Short-Acting Anesthetic Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Short-Acting Anesthetic Market Size by Type
  2. 10.1.1 China Short-Acting Anesthetic Revenue by Type (2021-2032)
  3. 10.1.2 China Short-Acting Anesthetic Sales by Type (2021-2032)
  4. 10.1.3 China Short-Acting Anesthetic Price by Type (2021-2032)
  5. 10.2 China Short-Acting Anesthetic Market Size by Application
  6. 10.2.1 China Short-Acting Anesthetic Revenue by Application (2021-2032)
  7. 10.2.2 China Short-Acting Anesthetic Sales by Application (2021-2032)
  8. 10.2.3 China Short-Acting Anesthetic Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Short-Acting Anesthetic Market Size by Type
  2. 11.1.1 Asia Short-Acting Anesthetic Revenue by Type (2021-2032)
  3. 11.1.2 Asia Short-Acting Anesthetic Sales by Type (2021-2032)
  4. 11.1.3 Asia Short-Acting Anesthetic Price by Type (2021-2032)
  5. 11.2 Asia Short-Acting Anesthetic Market Size by Application
  6. 11.2.1 Asia Short-Acting Anesthetic Revenue by Application (2021-2032)
  7. 11.2.2 Asia Short-Acting Anesthetic Sales by Application (2021-2032)
  8. 11.2.3 Asia Short-Acting Anesthetic Price by Application (2021-2032)
  9. 11.3 Asia Short-Acting Anesthetic Market Size by Country
  10. 11.3.1 Asia Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Short-Acting Anesthetic Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Short-Acting Anesthetic Market Size by Type
  2. 12.1.1 SAMEA Short-Acting Anesthetic Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Short-Acting Anesthetic Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Short-Acting Anesthetic Price by Type (2021-2032)
  5. 12.2 SAMEA Short-Acting Anesthetic Market Size by Application
  6. 12.2.1 SAMEA Short-Acting Anesthetic Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Short-Acting Anesthetic Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Short-Acting Anesthetic Price by Application (2021-2032)
  9. 12.3 SAMEA Short-Acting Anesthetic Market Size by Country
  10. 12.3.1 SAMEA Short-Acting Anesthetic Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Short-Acting Anesthetic Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Short-Acting Anesthetic Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Short-Acting Anesthetic Value Chain Analysis
  2. 13.1.1 Short-Acting Anesthetic Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Short-Acting Anesthetic Production Mode & Process
  6. 13.2 Short-Acting Anesthetic Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Short-Acting Anesthetic Distributors
  9. 13.2.3 Short-Acting Anesthetic Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst